Carlo Fremd

4PUBLICATIONS
21CO-AUTHORS
Toxicology (incl. clinical toxicology)Exercise physiologyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 25, 2026
Consensus on the Management of Inavolisib Side Effects. A Survey on Defined Side Effects, the Assumed Pathomechanism, Preventative and/or Therapeutic Measures Including the Integration of Additional Health Care Professionals - a Consensus Paper.

|Jul 25, 2024
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial.

Anouk E Hiensch, Johanna Depenbusch, Martina E Schmidt

|Dec 22, 2023
Non-Response of Epstein-Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases.

Ewgenija Gutjahr, Carlo Fremd, Johanna Arnscheidt

|Nov 04, 2022
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.

Stefanie Fischer, Thorsten O Götze, Aurelius Omlin

Pageof 1

Frequent Collaborators

1 joint publications

Stefanie Fischer

1 joint publications

Aurelius Omlin

1 joint publications

Richard D Baird

1 joint publications

Keith M Dawson